Abstract

Glioma is one of the most common and deadly malignant brain tumors originating from glial cells. For personalized treatment, an accurate preoperative prognosis for glioma patients is highly desired. Recently, various machine learning-based approaches have been developed to predict the prognosis based on preoperative magnetic resonance imaging (MRI) radiomics, which extract quantitative features from radiographic images. However, major challenges remain for methodologic developments to optimize feature extraction and provide rapid information flow in clinical settings. This study investigates two machine learning-based prognosis prediction tasks using radiomic features extracted from preoperative multimodal MRI brain data: (i) prediction of tumor grade (higher-grade vs. lower-grade gliomas) from preoperative MRI scans and (ii) prediction of patient overall survival (OS) in higher-grade gliomas (<12 months vs. > 12 months) from preoperative MRI scans. Specifically, these two tasks utilize the conventional machine learning-based models built with various classifiers. Moreover, feature selection methods are applied to increase model performance and decrease computational costs. In the experiments, models are evaluated in terms of their predictive performance and stability using a bootstrap approach. Experimental results show that classifier choice and feature selection technique plays a significant role in model performance and stability for both tasks; a variability analysis indicates that classification method choice is the most dominant source of performance variation for both tasks.

Highlights

  • Glioma is one of the most common and deadly malignant brain tumors originating from glial cells

  • Models are assessed in terms of their predictive performance and stability using a bootstrap approach based on the 2017 BraTS Challenge’s magnetic resonance imaging (MRI) data

  • We investigate two machine learning classification tasks using radiomic features: (i) prediction of tumor grade and (ii) prediction of overall survival in higher-grade gliomas ( 12 months). ese tasks are attempted using machine learning models constructed with various classifier methods and dimensionality reduction techniques

Read more

Summary

Introduction

Glioma is one of the most common and deadly malignant brain tumors originating from glial cells. About 50 percent of nervous system tumors and 80 percent of all malignant brain tumors are gliomas. Glioblastoma multiforme (GBM) ( called glioblastoma) is a fast-growing glioma that develops from star-shaped glial cells (astrocytes and oligodendrocytes) that support the health of the nerve cells within the brain. GBM occurs most often in the cerebral hemispheres, especially in the brain’s frontal and temporal lobes of the brain. GBM is a devastating brain cancer that typically results in death in the first 15 months after diagnosis. Traditional treatment of GBM is surgical resection followed by radiation therapy and/or chemotherapy

Methods
Findings
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call